DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen
07 nov. 2024 08h00 HE
|
DiagnaMed Holdings Corp.
Advancing molecular hydrogen for neurological and mental health disorders Expects its molecular hydrogen product to be ready for use in December 2024 TORONTO, Nov. 07, 2024 (GLOBE NEWSWIRE) --...
DiagnaMed Advancing the Medical Potential of Hydrogen
30 oct. 2024 08h00 HE
|
DiagnaMed Holdings Corp.
TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a life sciences company focused on brain health, announces its...